Genetic testing should also be considered for all patients with a diagnosis of gastric neoplasia and a family history compatible with Lynch syndrome, FAP, Peutz–Jeghers, Li–Fraumeni, juvenile polyposis, hereditary breast and ovarian cancer syndrome (germline mutations in BRCA1 or BRCA2). This evidence concerns the gene BRCA2 and juvenile polyposis syndrome.